|
⚲
|
| Keyboard |
| P2 Capital Partners LLC
✚
|
|
|---|---|
| CRD # | 159299 |
| SEC # | 801-73830 |
| CIK # | 0001406313 |
| AUM | 824.4 M (2026-04-01) |
| Employees | 14 (64% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-508-5500 |
| Address | 590 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (4/1/2026) [Brochure] |
|---|
Item 5: Fees and Compensation Adviser Compensation P2 is compensated for providing services to the Private Funds as established in each Private Fund’s COM. The compensation includes both management fees and performance-based fees, which are negotiated on a fund-by-fund basis. P2 and/or the P2 Fund GPs have the authority to deduct management and performance- based fees from the assets of the Private Funds and to authorize the payment of other fees/expenses to third- parties from the assets of the Private Funds. Management fees generally range from 1.0% to 2.0% (depending on the particular Private Fund and the particular class of limited partnership interests or shares that an underlying investor has invested in) calculated on the investor’s capital account balance as of the end of the specified fee period. Generally, management fees are paid either quarterly in arrears or quarterly in advance (less than six months in advance). For the Private Funds that pay in advance, the Private Fund documents provide that, upon termination, P2 will refund all management and other fees for which services have not been rendered. Each of the Private Fund agreements provides for the allocation of performance-based fees in the form of profit allocations to the relevant P2 Fund GP as carried interest. The Private Funds generally have a profit allocation ranging from 10% to 20% (depending on the particular Private Fund and the particular class of limited partnership interests or shares that an underlying investor has invested in) of the net profits attributable to each investor, which is paid to the P2 Fund GP of the Private Funds either at the end of the specified fee period or upon withdrawal of capital. For withdrawals, the profit allocation only applies with respect to the amount of capital withdrawn. The profit allocation is calculated as specified in each Private Fund's COM. Depending on the particular Private Fund (and the different investor classes, as available for a particular Private Fund), high water marks, hurdle rates and preferred returns may apply to the profit allocation. P2's performance fee is charged in compliance with Rule 205-3 under the Advisers Act. Although the Private Funds have different fee structures, P2 avoids the potential conflict of favoring those with higher overall fee structures by adhering to investment allocation procedures that promote the fair and equitable treatment of investment allocations over time. Allocation of Fees and Expenses In addition to P2’s management and performance-based fees, the Private Fund investors will bear various other fees and expenses charged to the Private Funds. Those fees will vary, but typically include fees such as brokerage (see “Item 12” of this Brochure for more information and details regarding P2’s brokerage practices), custodial and administration fees, directors fees, commissions and related costs, interest costs, insurance costs, legal fees, accounting, audit and tax preparation fees, taxes, costs associated with reporting and providing information to existing or prospective investors, investment and investment-related expenses, including research expenses, travel expenses, third-party valuation expenses and transaction and due diligence expenses (whether or not the transaction or investment is consummated). Some of these expenses, such as expenses in connection with a portfolio investment or proposed portfolio investment, are shared among the Private Funds, and in such case, are allocated to the Private Funds based on their pro rata share of these costs, at the sole discretion of P2. P2 is authorized to incur these expenses on behalf of the Private Funds; when this occurs, the respective Private Funds reimburse P2 in the amount of such expenses. Generally, P2 deducts management fees, performance fees and other fees and expenses from the Private Funds by instructing the Private Fund’s administrator to do so. Prospective and existing investors in the Private Funds are advised to review the applicable Private Fund COM for a more extensive description of the fees and expenses associated with an investment in the Private Funds. Certain investors in the Private Funds, which are generally employees of P2, may not pay management and/or performance-based fees on their investment in the Private Funds. Notwithstanding this exception, such investors do pay their pro rata share of all other Private Fund expenses. P2 also receives certain fees in connection with its private equity investments. These fees are allocated to the Private Funds based on each Private Fund’s operating agreements with P2 and are generally used to offset management fees, as more fully described in each Private Fund’s COM. |
| Account Minimums and Types of Clients — Form ADV Part 2A (4/1/2026) [Brochure] |
|---|
Item 7: Types of Clients As described in Item 4 above, P2’s sole clients are the Private Funds. Limited partners and shareholders in the Private Funds are generally required to make a minimum investment in such Private Fund, as set forth in each Private Fund’s COM. However, these minimum requirements may be waived in the discretion of P2 or the applicable P2 Fund GP of the Private Fund. Interests in the Private Funds may be purchased only by investors that are “qualified purchasers” for purposes of section 3(c)(7) of the Investment Company Act of 1940, as amended. Investors in the Private Funds include corporate and state pension plans, trusts, endowments, foundations, charitable organizations, corporations, limited partnerships, limited liability companies, high-net-worth individuals and employees. |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| Acadia Healthcare Company Inc | 41.5 | |
| CBIZ Inc | 30.6 | |
| John Bean Technologies Corp | 28.8 | |
| Henry Schein Inc | 22.1 | |
| Tennant Co | 20.2 | |
| Blackbaud Inc | 18.6 | |
| Mine Safety Appliances Co | 16.9 | |
| Zeta Global Holdings Corp | 14.6 | |
| Livanova PLC | 9.3 | |
| Colfax Corp | 7.3 |
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | P2 Capital Master Fund XIV LLC | [2025-03-31] | 37.3 M | 23.3 M |
| Filed 2025-11-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | P2 Capital Master Fund XIII LP | [2019-03-29] | 329.5 M | |
| Filed 2018-04-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | P2 Capital Master Fund XII LP | 2017-03-31 | 279.4 M | |
| PE | P2 Capital Master Fund Xi LP | [2017-03-31] | 6.8 M | |
| Filed 2016-05-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | P2 Capital Master Fund X LP | [2015-03-31] | 175.9 M | 197.2 M |
| Filed 2015-03-10 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | P2 Capital Master Fund IX LP | 2014-03-31 | 80.0 M | |
| HF | P2 Capital Master Fund VIII LLC | 2013-04-01 | 21.9 M | |
| PE | P2 Capital Master Fund VII LP | [2013-04-01] | 119.9 M | 229.5 M |
| Filed 2013-04-18 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $450,000 · Revenue Decline to Disclose | ||||
| PE | P2 Capital Fund IV LP | [2012-02-14] | 36.8 M | 1.5 M |
| Filed 2010-09-29 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | P2 Capital Master Fund III LLC | [2012-02-14] | 35.0 M | 53.2 M |
| Filed 2011-12-29 (D/A) · Exemption 506, 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 0.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 0.8 |
| By Discretionary | ||
| Discretionary | 5 | 0.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 0.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.5 | |
| United States Persons | 0.4 | |
| Total | 5 | 0.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Claus Moller | Executive Officer | 23 | 2 | |
| P2 Capital GP IV LLC | Promoter | 2 | 2 | |
| P2 Capital GP XIII LLC | Promoter | 1 | 1 | |
| P2 Capital GP II LLC | Promoter | 1 | 1 | |
| P2 Capital GP VII LLC | Promoter | 1 | 1 | |
| P2 Capital GP V LLC | Promoter | 1 | 1 | |
| P2 Capital GP Xi LLC | Promoter | 1 | 1 | |
| P2 Capital GP X LLC | Promoter | 1 | 1 | |
| P2 Capital GP LLC | Promoter | 1 | 1 | |
| P2 Capital GP XIV LLC | Promoter | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001406313] | |
| 3 | [0001406313] | |
| 4 | [0001406313] | |
| SC 13D | [0001406313] | |
| SC 13G | [0001406313] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $1.2B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 5493001KJTIIGC8Y1R12 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bioanalytical Systems Inc NOTV
Common Shares
|
2022-09-16 | Other | 2,231,256 | $0.00 | |
|
Bioanalytical Systems Inc NOTV
Common Shares
|
2022-09-16 | Other | 2,946,961 | $0.00 | |
|
Bioanalytical Systems Inc NOTV
Common Shares
|
2022-09-16 | Other | 63,758 | $0.00 | |
|
Bioanalytical Systems Inc NOTV
Common Shares
|
2022-09-16 | Other | 715,705 | $0.00 | |
|
Bioanalytical Systems Inc NOTV
Common Shares
|
2022-09-16 | Other | 2,231,256 | $0.00 | |
|
Blount International Inc BLT
Common Stock
|
2016-04-12 | Other | 1,273,215 | $10.00 | 12,732,150 |
|
Blount International Inc BLT
Common Stock
|
2016-04-12 | Other | 2,127,405 | $10.00 | 21,274,050 |
|
Blount International Inc BLT
Common Stock
|
2016-04-12 | Other | 3,833,583 | $10.00 | 38,335,830 |
|
UTi Worldwide Inc UTIW
7.00% Convertible Preference Shares · derivative
|
2015-12-01 | Other | 0 | ||
|
UTi Worldwide Inc UTIW
Ordinary Shares
|
2015-11-25 | Other | 2,101,674 | $6.98 | 14,669,685 |
|
Blount International Inc BLT
Common Stock
|
2015-11-24 | Sell | 6,336 | $5.44 | 34,468 |
|
Blount International Inc BLT
Common Stock
|
2015-11-24 | Sell | 10,587 | $5.44 | 57,593 |
|
Blount International Inc BLT
Common Stock
|
2015-11-24 | Sell | 19,077 | $5.44 | 103,779 |
|
Blount International Inc BLT
Common Stock
|
2015-11-23 | Sell | 18,304 | $5.28 | 96,645 |
|
Blount International Inc BLT
Common Stock
|
2015-11-23 | Sell | 55,112 | $5.28 | 290,991 |
|
Blount International Inc BLT
Common Stock
|
2015-11-23 | Sell | 30,584 | $5.28 | 161,484 |
|
UTi Worldwide Inc UTIW
7.00% Convertible Preference Shares · derivative
|
2015-09-01 | Other | 0 | ||
|
UTi Worldwide Inc UTIW
Common Stock
|
2015-07-28 | Buy | 437,930 | $8.19 | 3,586,647 |
|
UTi Worldwide Inc UTIW
Common Stock
|
2015-07-28 | Buy | 437,070 | $8.19 | 3,579,603 |
|
UTi Worldwide Inc UTIW
7.00% Convertible Preference Shares · derivative
|
2015-06-01 | Other | 0 | ||
| showing 20 of 40 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Eagle's View Capital Management LLC
✚
|
NY | 860.5 M |
|
Arosa Capital Management LP
✚
|
FL | 856.6 M |
|
GFO Asset Management LLC
✚
|
FL | 856.1 M |
|
CPMG Inc
✚
|
TX | 855.8 M |
|
First Citizens Institutional Asset Management LLC
✚
|
NY | 829.2 M |
|
MYDA Advisors LLC
✚
|
NY | 821.2 M |
|
Segra Capital Management LLC
✚
|
FL | 820.7 M |
|
Poetic Group LLC
✚
|
NJ | 802.5 M |
|
Lapis Advisers LP
✚
|
CO | 789.5 M |
|
Softvest Advisors LLC
✚
|
TX | 788.2 M |